Talk:Levetiracetam

message: When I take Keppra, I will have a total loss of Ego. I will not respond, or even understand anything asked of me. This may be an unusual symptom, but I was told my my doctor that this is not too uncommon. That is why I feel it must be mentioned here until I (Or another) can find a quotable reference to this. (Sorry for editing the main article improperly, and thank you SpikeToronto for patiently explaining this to me.)  —Preceding unsigned comment added by 68.189.219.105 (talk) 08:38, 24 October 2010 (UTC)
thread_title:  other side effects from those listed 

message: I believe this junk is useless for most people. I believe it is only promoted by the pharmaceutical companies because it is one of the more profitable possible treatments for seizures to make and sell. (I need a citation for this obviously) Levitaracetam winds up costing thousands of USD per kilogram. Conversely, Piracetam is easily less than a hundred USD per kilogram. — Preceding unsigned comment added by 68.189.219.105 (talk) 20:58, 28 October 2010
:As far as I can tell, the indications for levetiracetam and piracetam are totally different, perhaps even opposite in terms of effects with calcium, so it is meaningless to compare their prices. --IO Device (talk) 23:10, 6 June 2013 (UTC)
thread_title:  My own negative opinion 

message: Another side affects of levetiracetam is heavy weight loss and mood swing
positive side is defintely controlling the seizures and also I had taken medicine while feeding my baby around a year , could not find any developmental problems or delays in my child  —Preceding unsigned comment added by padma divakaruni68.126.151.18 (talk) 23:17, 24 March 2011 (UTC)
thread_title:  Just another note 

message: The edit of 09:01, 11 December 2011 by 14.96.168.254 created the subsection "Assay of Levetiracetam" but incorrectly (see MOS:HEAD) included a cite ref in the subsection heading. Do you have access to the cited source? If so, would you move the cite ref to the appropriate place within the body text of that subsection, or at least explain here what part(s) of that subsection the source does and doesn't support? Thanks, --Rich Janis (talk) 04:34, 10 October 2013 (UTC)
thread_title:  Assay of Levetiracetam 

message: We made changes to strengthen the lead section and provided more information about special populations, mechanism of action, and adverse effects.  We also added new sections on warnings and pharmacokinetics.  Furthermore, we removed any information that was not properly cited or cited from unreliable sources.  — Preceding unsigned comment added by Keppra28 (talk • contribs) 07:45, 5 November 2015 (UTC)
thread_title:  Keppra28 Edits 

message: -Does this draft submission reflect a neutral point of view (yes/no)? Yes
-Are the points included verifiable with cited published material (yes/no)? Yes
-What recommendations can you provide your colleague for improvement of their draft? Suggestions for improvement include using lay language and correcting medical jargon such as “renal excretion” or “CNS” (there was no explanation or statement that CNS stands for central nervous system) so that the information can be more clear to the general public. In addition, there are sections that are not relevant to the general public such as the information on special populations, absorption, distribution, metabolism, and excretion of levetiracetam. In addition, the “measurement in bodily fluids” section is difficult to understand, probably not relevant to the public, and not clear in the conclusions of therapeutic drug monitoring methods of levetiracetam.  — Preceding unsigned comment added by Meghanw27 (talk • contribs) 19:14, 9 November 2015 (UTC)
thread_title:  Course Peer Review Edit Suggestions